General

Shooting Stars: Rocket Lab Breaks Records (And Stock Up 640% In Past Year), AST SpaceMobile Impresses Defense, Kuiper Grows

20 Surprising Reddit Facts To Celebrate Its Milestone Birthday

Vor Biopharma's RemeGen Deal Paves Way For Multi-Billion Dollar Autoimmune Market

20 Surprising Reddit Facts To Celebrate Its Milestone Birthday

Vor Biopharma's RemeGen Deal Paves Way For Multi-Billion Dollar Autoimmune Market

Aardvark's Hunger-Suppressing Drug Promises Weight Loss Without GI Distress

Amgen's Gastric Cancer Drug Improves Survival In Phase 3, Notes Ocular Side Effects

Aardvark's Hunger-Suppressing Drug Promises Weight Loss Without GI Distress

Amgen's Gastric Cancer Drug Improves Survival In Phase 3, Notes Ocular Side Effects

Moderna's mRNA Flu Vaccine Outperforms Standard Shots

Why Is Hewlett Packard Stock Soaring On Monday?

General Recent News

Emmanuel Macron Calls Tariffs 'Blackmail,' White House Shoots Back Saying Trump Is 'Doing What's Right For Our People'

Robinhood, Apple, Oracle, Plug Power And Tesla: Why These 5 Stocks Are On Investors' Radars Today

On Monday, major U.S. indices closed in positive territory, with the Dow Jones Industrial Average rising 0.6% to 44,094.77.

Globalization Has Been Great For US Corporate Profit Margins

it's hard to see how new tariffs or any other policy that disincentivizes globalization wouldn't eventually lead to higher cost inflation.

FDA Flags Major Safety Concerns For Argenx's Nerve Disorder Drug, Stock Falls

FDA raised safety concerns for Vyvgart Hytrulo in CIDP, while Argenx moves ARGX-119 into late-stage trials for rare neuromuscular disease.

Alzheimer's Setback Hits INmune Bio Stock, But FDA Hopes Remain

INmune Bio's Alzheimer's drug XPro showed targeted benefits in patients with brain inflammation, but misses the main trial endpoint.

SocialFi Fizzled Out, Now It's Set For A Comeback.

The first wave was too much social, not enough DeFi. Now things look set to change.

This Penny Stock Exploded 500% In June: What You Need To Know

Shares of the anti-aging biogenetics company Klotho Neurosciences are on retail investors' radars after the stock exploded more than 500% in June.

FDA Raises Manufacturing Concerns, Delays Unicycive's Kidney Disease Drug Approval

FDA denies Unicycive's NDA for Oxylanthanum Carbonate due to vendor issues; company eyes quick resolution with alternate manufacturer in place.

Why Is Micro-Cap Artelo Biosciences Stock Trading Higher On Monday?

Artelo reports favorable Phase 1 results for its FABP5 inhibitor, showing strong safety data and dose-dependent absorption in 49 healthy participants.

East Vs. West: The AI Data Battle Between Publishers And LLMs

Discover the AI data revolution unfolding on America's coasts as a East Coast publisher takes on a West Coast tech titan.

FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers

FDA lifts REMS for approved CAR-T therapies, easing hospital restrictions and signaling broader future access in oncology and autoimmune treatment.

EXCLUSIVE: MIRA Pharmaceuticals' Soon To Be Acquired Weight Loss Drug Reverses Obesity Markers And Cuts Nicotine Craving In Animal Study

MIRA's to be acquired SKNY-1 cut weight and food cravings in animals, reversed liver fat, and reduced nicotine desire—without triggering muscle loss or overstimulation.

Jeff Bezos Texted And Then Chamath Palihapitiya Sent A Plane Loaded With Bottles Of His $1,200 Tequila To Venice As Wedding Present

Palihapitiya sent Bezos a case of his $1,200 tequila as a wedding gift after the Amazon founder requested a last-minute delivery to his Venice nuptials.